Newsfeeds - Spark Newswire

1 minute read

If You Invested $100 In This Stock 15 Years Ago, You Would Have $1,000 Today

Today, 1:05 PM

Alnylam Pharmaceuticals (NASDAQ:ALNY) has outperformed the market over the past 15 years by 9.06% on an annualized basis producing an average annual return of 16.5%. Currently, Alnylam Pharmaceuticals has a market capitalization of $28.09 billion.

ALNY

1 minute read

Analyst Ratings

Where Alnylam Pharmaceuticals Stands With Analysts

By Benzinga Insights

Today, 1:05 PM

Within the last quarter, Alnylam Pharmaceuticals (NASDAQ:ALNY) has observed the following analyst ratings:

ALNY

1 minute read

Chardan Capital Maintains Buy on Alnylam Pharmaceuticals, Raises Price Target to $250

By Benzinga Newsdesk

Today, 1:05 PM

Chardan Capital analyst Keay Nakae maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and raises the price target from $200 to $250.

ALNY

8 minute read

This Biotechnology Stock Jumped Over 360%; Here Are 106 Biggest Movers From Yesterday

By Lisa Levin

Today, 1:05 PM

Gainers Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) shares surged 360.5% to settle at $19.80 on Wednesday on above-average volume.

AAWW

1 minute read

Needham Maintains Buy on Alnylam Pharmaceuticals, Raises Price Target to $240

By Benzinga Newsdesk

Today, 1:05 PM

Needham analyst Joseph Stringer maintains Alnylam Pharmaceuticals (NASDAQ:ALNY) with a Buy and raises the price target from $205 to $240.

ALNY

3 minute read

Moderna, PayPal And Some Other Big Gainers From Wednesday

By Lisa Levin

Today, 1:05 PM

U.S. stocks closed higher on Wednesday, with the Dow Jones gaining more than 400 points. Here is the list of some big stocks moving higher in the previous session.

AAWW

3 minute read

Recap Of Wednesday’s Biotech Catalysts – End Of the Day Summary

By Ragothaman Srinivasan

Today, 1:05 PM

The U.S. Food and Drug Administration (FDA) has accepted for review MediWound’s (NASDAQ:MDWD) recently re-submitted Biologics License Application…

ALNY

2 minute read

12 Health Care Stocks Moving In Wednesday’s Intraday Session

By Benzinga Insights

Today, 1:05 PM

ALNY

5 minute read

Why Poseida Therapeutics Almost Doubled Today, Here Are 75 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

Today, 1:05 PM

Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares jumped 167% to $1.72 after dropping 13% on Tuesday.

AAWW

2 minute read

Alnylam Shares Shoot Higher Following Positive Clinical Results From Late-Stage ATTR Amyloidosis Therapeutics

By Ragothaman Srinivasan

Today, 1:05 PM

Alnylam (NASDAQ: ALNY) announced positive results from the APOLLO-B Phase 3 study of Patisiran for the treatment of transthyretin-mediated (ATTR) amyloidosis with cardiomyopathy.

ALNY